Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo

• Published in: PloS one 2015-10, Vol.10 (10), p.e0139652
• Main Authors: Stalmans, Sofie, Bracke, Nathalie, Wynendaele, Evelien, Gevaert, Bert, Peremans, Kathelijne, Burvenich, Christian, Polis, Ingeborgh, De Spiegeleer, Bart
• Format: Article
• Language: English
• Subjects: Analogs; Animals; Biochemistry; Biological activity; Biological Transport; Blood-brain barrier; Blood-Brain Barrier - drug effects; Bovine serum albumin; Brain - drug effects; Brain - metabolism; Capillaries - metabolism; Cattle; Cell Membrane - metabolism; Cell Membrane Permeability; Cell membranes; Cell-Penetrating Peptides - chemistry; Coinjection; Efflux; Iodine Radioisotopes - chemistry; Kidney - drug effects; Liver - drug effects; Membrane permeability; Metabolism; Mice; Mice, Inbred ICR; Neurosciences; Parenchyma; Peptides; Permeability; Pharmaceutical sciences; Properties (attributes); Proteins; Quality; Registration; Regression Analysis; Serum albumin; Serum Albumin, Bovine - metabolism; Studies; Tissue Distribution; Transport properties; Veterinary medicine
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0139652

Cell-penetrating peptides (CPPs) are a group of peptides, which have the ability to cross cell membrane bilayers. CPPs themselves can exert biological activity and can be formed endogenously. Fragmentary studies demonstrate their ability to enhance transport of different cargoes across the blood-brain barrier (BBB). However, comparative, quantitative data on the BBB permeability of different CPPs are currently lacking. Therefore, the in vivo BBB transport characteristics of five chemically diverse CPPs, i.e. pVEC, SynB3, Tat 47-57, transportan 10 (TP10) and TP10-2, were determined. The results of the multiple time regression (MTR) analysis revealed that CPPs show divergent BBB influx properties: Tat 47-57, SynB3, and especially pVEC showed very high unidirectional influx rates of 4.73 μl/(g × min), 5.63 μl/(g × min) and 6.02 μl/(g × min), respectively, while the transportan analogs showed a negligible to low brain influx. Using capillary depletion, it was found that 80% of the influxed peptides effectively reached the brain parenchyma. Except for pVEC, all peptides showed a significant efflux out of the brain. Co-injection of pVEC with radioiodinated bovine serum albumin (BSA) did not enhance the brain influx of radiodionated BSA, indicating that pVEC does not itself significantly alter the BBB properties. A saturable mechanism could not be demonstrated by co-injecting an excess dose of non-radiolabeled CPP. No significant regional differences in brain influx were observed, with the exception for pVEC, for which the regional variations were only marginal. The observed BBB influx transport properties cannot be correlated with their cell-penetrating ability, and therefore, good CPP properties do not imply efficient brain influx.